The vulva is the external part of the female genitals, including the clitoris, the vaginal lips, the opening to the vagina, and the surrounding skin and tissue. Most vulvar cancers are squamous cell carcinoma.

This type of cancer begins in squamous cells (thin, flat skin cells) and is usually found on the vaginal lips. A small number of vulvar cancers are adenocarcinomas (cancers that begin in cells that make mucus and other fluids). This type of cancer is usually found on the sides of the vaginal opening.

Vulvar cancer usually forms slowly over a number of years. Abnormal cells can grow on the surface of the vulvar skin for a long time. This condition is called vulvar intraepithelial neoplasia (VIN).

Signs and symptoms of vulvar cancer may include:

• Itching that doesn’t go away
• Pain and tenderness
• Bleeding that isn’t from menstruation
• Skin changes, such as color changes or thickening
• A lump, wart-like bumps or an open sore (ulcer)

It’s not clear what causes vulvar cancer. In general, doctors know that cancer begins when a cell develops mutations in its DNA. The mutations allow the cell to grow and divide rapidly. The cell and its offspring go on living when other normal cells would die. The accumulating cells form a tumor that may be cancerous, invading nearby tissue and spreading to other parts of the body.

Vulvar cancer treatment usually involves surgery to remove the cancer and a small amount of surrounding healthy tissue. Sometimes vulvar cancer surgery requires removing the entire vulva. The earlier vulvar cancer is diagnosed, the less likely an extensive surgery is needed for treatment.

Surgery

Surgery used to treat vulvar cancer include:

• Removing the cancer and a margin of healthy tissue (excision).
• Removing a portion of the vulva (partial vulvectomy).
• Removing the entire vulva (radical vulvectomy).
• Extensive surgery for advanced cancer. If cancer has spread beyond the vulva and involves nearby organs, the doctor may recommend removing all of the vulva and the involved organs in a procedure called pelvic exenteration. The surgeon may remove the lower colon, rectum, bladder, cervix, uterus, vagina, ovaries and nearby lymph nodes depending where the cancer has spread.

Radiation therapy

Radiation therapy uses high-powered energy beams, such as X-rays, to kill cancer cells. Radiation therapy for vulvar cancer is usually administered by a machine that moves around the body and directs radiation to precise points on the skin (external beam radiation). Radiation therapy is sometimes used to shrink large vulvar cancers in order to make it more likely that surgery will be successful. If cancer cells are discovered in the lymph nodes, the doctor may recommend radiation to the area around the lymph nodes to kill any cancer cells that might remain after surgery.

Chemotherapy

For women with advanced vulvar cancer that has spread to other areas of the body, chemotherapy may be an option. Sometimes chemotherapy is combined with radiation therapy to shrink large vulvar cancers in order to make it more likely that surgery will be successful.

The Centers for Disease Control and Prevention (CDC) provides information, US statistics, and resources related to vaginal and vulvar cancer.

Globe-athon to End Women’s Cancer offers a collection of educational video lectures for the general public in which experts cover a variety of topics related to women’s cancer.

The National Cancer Institute is a reliable source for in-depth information about many cancers including treatment of vulvar cancer.

Global Cancer Observatory 2018 Fact Sheet on worldwide incidence, mortality and prevalence of vulvar cancer.

The Global Cancer Observatory  is an interactive web-based platform presenting global cancer statistics to inform cancer control and research.  It uses data from the International Agency for Research on Cancer which is a specialized agency of the World Health Organization. 

Vaginal cancer is a rare cancer that occurs in the vagina, the muscular tube that connects the uterus to the outer genitals. It most commonly occurs in the cells that line the surface of the vagina, which is sometimes called the birth canal. While several types of cancer can spread to the vagina from other places in the body, cancer that begins in the vagina (primary vaginal cancer) is rare.

Vaginal cancer is divided into different types based on the type of cell where the cancer began.

1. Vaginal squamous cell carcinoma, which begins in the thin, flat cells (squamous cells) that line the surface of the vagina, and is the most common type
2. Vaginal adenocarcinoma, which begins in the glandular cells on the surface of the vagina
3. Vaginal melanoma, which develops in the pigment-producing cells (melanocytes) of the vagina
4. Vaginal sarcoma, which develops in the connective tissue cells or muscles cells in the walls of the vagina

Early vaginal cancer may not cause any signs and symptoms. It may be found during a routine pelvic exam and Pap test. As it progresses, vaginal cancer may cause signs and symptoms such as:

• Unusual vaginal bleeding, for example, after intercourse or after menopause
• Watery vaginal discharge
• A lump or mass in your vagina
• Painful urination
• Frequent urination
• Constipation
• Pelvic pain

It’s not clear what causes vaginal cancer. Infection with human papillomavirus (HPV) causes two-thirds of the cases of vaginal cancer. Vaccines that protect against infection with HPV may reduce the risk of vaginal cancer. In general, cancer begins when healthy cells acquire a genetic mutation that turns normal cells into abnormal cells. Healthy cells grow and multiply at a set rate, eventually dying at a set time. Cancer cells grow and multiply out of control, and they don’t die. The accumulating abnormal cells form a mass (tumor). Cancer cells invade nearby tissues and can break off from an initial tumor to spread elsewhere in the body (metastasize).  

Treatment options for vaginal cancer depend on several factors, including the type of vaginal cancer and its stage. Treatment for vaginal cancer typically includes surgery and radiation.

Surgery

Types of surgery that may be used to treat vaginal cancer include:

• Removal of small tumors or lesions. Cancer limited to the surface of the vagina may be cut away, along with a small margin of surrounding healthy tissue to ensure that all of the cancer cells have been removed.
• Removal of the vagina (partial or full).
• Removal of the majority of the pelvic organs (pelvic exenteration). This extensive surgery may be an option if cancer has spread throughout the pelvic area or if vaginal cancer has recurred. During pelvic exenteration, the bladder, ovaries, uterus, vagina, rectum and the lower portion of the colon may be removed.

Radiation Therapy

Radiation therapy uses high-powered energy beams, such as X-rays, to kill cancer cells. Radiation can be delivered externally or internally (brachytherapy) or both.

Chemotherapy

If surgery and radiation does not control the cancer, chemotherapy may be offered. It is unclear whether chemotherapy is useful for treating vaginal cancer and generally isn’t used on its own to treat vaginal cancer. Chemotherapy may be used during radiation therapy to enhance the effectiveness of radiation. See the National Cancer Institute’s Treatment Summary for Vaginal Cancer for more information.

The Centers for Disease Control and Prevention (CDC) provides information, US statistics, and resources related to vaginal and vulvar cancer.

Globe-athon to End Women’s Cancer offers a collection of educational video lectures for the general public in which experts cover a variety of topics related to women’s cancer.

The National Cancer Institute is a reliable source for in-depth information about many cancers including vaginal cancer.

Global Cancer Observatory 2018 Fact Sheet on worldwide incidence, mortality and prevalence of vaginal cancer.

The Global Cancer Observatory  is an interactive web-based platform presenting global cancer statistics to inform cancer control and research.  It uses data from the International Agency for Research on Cancer which is a specialized agency of the World Health Organization. 

Endometrial cancer is a type of cancer that begins in the uterus, the hollow, pear-shaped pelvic organ in women where fetal development occurs. Endometrial cancer begins in the layer of cells that form the lining (endometrium) of the uterus. Other types of cancer can form in the uterus, including uterine sarcoma, but they are much less common than endometrial cancer.

Endometrial cancer is often detected at an early stage because it frequently produces abnormal vaginal bleeding, which prompts women to see their doctors. Signs and symptoms of endometrial cancer may include:

• Vaginal bleeding after menopause
• Bleeding between periods
• An abnormal, watery or blood-tinged discharge from your vagina
• Pelvic pain

Doctors don’t know what causes endometrial cancer. What’s known is that something occurs to create a genetic mutation within cells in the endometrium — the lining of the uterus. The genetic mutation turns normal, healthy cells into abnormal cells. Healthy cells grow and multiply at a set rate, eventually dying at a set time. Abnormal cells grow and multiply out of control, and they don’t die at a set time. The accumulating abnormal cells form a mass (tumor). Cancer cells invade nearby tissues and can separate from an initial tumor to spread elsewhere in the body (metastasize).

Options for treating endometrial cancer will depend on the characteristics of cancer, such as the stage, the patient’s general health and preferences. If endometrial cancer is discovered early, removing the uterus surgically often cures endometrial cancer. Other treatments include radiation therapy, chemotherapy, hormone therapy and biologic therapy. New types of targeted therapy are being tested in clinical trials. Please visit the National Cancer Institute (NCI) for more detailed treatment information about uterine cancer.

• Treatment of Endometrial Cancer
• Treatment of Uterine Sarcoma

The Centers for Disease Control and Prevention (CDC) provides information, US statistics, and resources related to uterine cancer.

Globe-athon to End Women’s Cancer offers a collection of educational video lectures for the general public in which experts cover a variety of topics related to women’s cancer.

The National Cancer Institute is a reliable source for in-depth information about many cancers including prevention, screening, treatment and research for uterine cancer.

Global Cancer Observatory 2018 Fact Sheet on worldwide incidence, mortality and prevalence of ovarian cancer.

The Global Cancer Observatory  is an interactive web-based platform presenting global cancer statistics to inform cancer control and research.  It uses data from the International Agency for Research on Cancer which is a specialized agency of the World Health Organization. 

Ovarian cancer begins in the ovaries, the reproductive glands on each side of the uterus that produce eggs and hormones. Ovarian cancer often goes undetected until it has spread within the pelvis and abdomen. At this late stage, ovarian cancer is more difficult to treat and is frequently fatal. Early-stage ovarian cancer, in which the disease is confined to the ovary, is more likely to be treated successfully.

The ovaries are made of three main kinds of cells. Each can develop into a different type of tumor:

1. Epithelial tumors, which begin in the thin layer of tissue that covers the outside of the ovaries. About 90 percent of ovarian cancers are epithelial tumors.
2. Stromal tumors, which begin in the ovarian tissue that contains hormone-producing cells. These tumors are usually diagnosed at an earlier stage than other ovarian tumors. About 7 percent of ovarian tumors are stromal.
3. Germ cell tumors, which begin in the egg-producing cells. These rare ovarian cancers tend to occur in younger women.

Early-stage ovarian cancer rarely causes any symptoms. Advanced-stage ovarian cancer may cause few and nonspecific symptoms that are often mistaken for more common benign conditions, such as constipation or irritable bowel. Signs and symptoms of ovarian cancer may include:

• Abdominal bloating or swelling
• Quickly feeling full when eating
• Weight loss
• Discomfort in the pelvis area
• Changes in bowel habits, such as constipation
• A frequent need to urinate

In general, cancer begins when a genetic mutation turns normal cells into abnormal cancer cells. Cancer cells quickly multiply, forming a mass (tumor). They can invade nearby tissues and break off from an initial tumor to spread elsewhere in the body (metastasize). A woman’s lifetime risk of developing breast and/or ovarian cancer is greatly increased if she inherits a harmful mutation in BRCA1 or BRCA2. Learn more about BRCA mutations, cancer risk, and genetic testing at the National Cancer Institute.

Standard treatment of ovarian cancer usually involves surgery, chemotherapy and/or targeted therapy. New types of treatment are being tested in clinical trials. Patients with any stage of ovarian cancer may want to think about taking part in a clinical trial.

Surgery

Treatment generally involves removing both ovaries, the fallopian tubes, the uterus as well as nearby lymph nodes and a fold of fatty abdominal tissue (omentum) where ovarian cancer often spreads. Less extensive surgery may be possible if the cancer was diagnosed at a very early stage. For women with stage I ovarian cancer, surgery may involve removing one ovary and its fallopian tube.

Chemotherapy

After surgery, chemotherapy will likely be administered to kill any remaining cancer cells. Chemotherapy drugs can be injected into a vein or directly into the abdominal cavity or both. Chemotherapy may be used as the initial treatment in some women with advanced ovarian cancer.

Targeted Therapy

Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Targeted therapies are usually referred to as maintenance therapies to prevent recurrence although some may be given with chemotherapy during initial treatment and then continued after chemotherapy.

• Monoclonal antibody therapy is a type of targeted therapy that uses antibodies made in the laboratory, from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells.
• Poly (ADP-ribose) polymerase inhibitors (PARP inhibitors) are targeted therapy drugs that block DNA repair and may cause cancer cells to die.
• Angiogenesis inhibitors are targeted therapy drugs that may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells.

Visit the National Cancer Institute (NCI) for more detailed information about the treatment of ovarian cancer.

• Treatment of Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer
• Treatment of Ovarian Germ Cell Tumors
• Treatment of Ovarian Low Malignant Potential Tumors 

The Centers for Disease Control and Prevention (CDC) provides information, US statistics, and resources related to ovarian cancer.

Globe-athon to End Women’s Cancer offers a collection of educational video lectures for the general public in which experts cover a variety of topics related to women’s cancer.

The National Cancer Institute (NCI) is a reliable source for in-depth information about many cancers including prevention, screening, treatment and research for ovarian, fallopian tube, and primary peritoneal cancer.

SurvivorNet provides videos and articles for the general public vetted by experts in gynecologic oncology. The content covers a variety of topics related to ovarian cancer.

Facing Our Risk of Cancer Empowered (FORCE) provides resources to improve the lives of individuals and families affected by hereditary breast, ovarian, and related cancers.

Global Cancer Observatory 2018 Fact Sheet on worldwide incidence, mortality and prevalence of ovarian cancer.

The Global Cancer Observatory  is an interactive web-based platform presenting global cancer statistics to inform cancer control and research.  It uses data from the International Agency for Research on Cancer which is a specialized agency of the World Health Organization. 

 

 

Cervical cancer occurs in the cells of the cervix — the lower part of the uterus that connects to the vagina. The most common type of cervical cancer is squamous cell carcinoma which begins in squamous cells (thin, flat skin cells) on the wall of the cervix. However, some cervical cancers are adenocarcinomas (cancers that begin in cells that make mucus and other fluids).  While most cervical cancers are squamous cell carcinomas, both types of cells may be involved in cervical cancer in some instances. Very rarely, cancer occurs in other cells of the cervix.

Early-stage cervical cancer generally produces no signs or symptoms. Signs and symptoms of more-advanced cervical cancer include:

• Vaginal bleeding after intercourse, between periods or after menopause
• Watery, bloody vaginal discharge that may be heavy and have a foul odor
• Pelvic pain or pain during intercourse

It isn’t clear what causes cervical cancer, but it’s certain that various strains of the human papilloma virus (HPV), a sexually transmitted infection, plays a role. When exposed to HPV, a woman’s immune system typically prevents the virus from doing harm. In a small group of women, however, the virus survives for years, contributing to the process that causes some cells on the surface of the cervix to become cancer cells. HPV is very common, and most women with the virus never develop cervical cancer. This means other factors, such as environment and lifestyle choices, also determine whether a woman will develop cervical cancer.

Treatment for cervical cancer depends on several factors, such as the stage of the cancer, other health problems the patient may have and the patient’s preferences. Surgery, radiation, chemotherapy or a combination of the three may be used.

Screening

Cervical cancer that is detected early is more likely to be treated successfully. Most guidelines suggest that women begin screening for cervical cancer and precancerous changes at age 21. Women can reduce their risk of developing cervical cancer by having screening tests and receiving a vaccine that protects against HPV infection. Screening tests include the PAP test and the HPV DNA test.

Surgery

Early-stage cervical cancer is typically treated with surgery to remove the uterus (hysterectomy). A hysterectomy can cure early-stage cervical cancer and prevent recurrence. Minimally invasive surgery may be an option for early-stage cervical cancer.

Radiation

Radiation therapy uses high-powered energy beams, such as X-rays or protons, to kill cancer cells. Radiation therapy may be used alone or with chemotherapy before surgery to shrink a tumor or after surgery to kill any remaining cancer cells. Radiation may be given externally, internally or both.

Chemotherapy

Chemotherapy uses medications, usually injected into a vein, to kill cancer cells. Low doses of chemotherapy are often combined with radiation therapy, since chemotherapy may enhance the effects of the radiation. Higher doses of chemotherapy are used to control advanced cervical cancer that may not be curable.

The Centers for Disease Control and Prevention (CDC) provides information, US statistics, and resources related to cervical cancer, including information about low-cost screening in the United States.

Globe-athon to End Women’s Cancer offers a collection of educational video lectures for the general public in which experts cover a variety of topics related to women’s cancer.

The National Cancer Institute  (NCI) is a reliable source for in-depth information about many cancers including prevention, screening, treatment and research for cervical cancer.

Cervical cancer is one of the most preventable and treatable forms of cancer, yet it remains one of the most common causes of death for women. Nearly 90% of deaths from cervical cancer each year are of women living in low- and middle- income countries.

Global Cancer Observatory 2018 Fact Sheet on worldwide incidence, mortality and prevalence of cervical cancer.

The Global Cancer Observatory  is an interactive web-based platform presenting global cancer statistics to inform cancer control and research.  It uses data from the International Agency for Research on Cancer which is a specialized agency of the World Health Organization. 

Cervical Cancer Free Coalition: Global Crisis of Cervical Cancer

World Health Organization (WHO) Initiative to Eliminate Cervical Cancer